PGAM1 and schizophrenia: Proteomics in the prefrontal cortex and cerebrospinal fluid of patients with schizophrenia have shown altered levels of glycolytic enzymes, including a reduction in PGAM1 expression [49,50], which was also observed in a phencyclidine animal model of schizophrenia [51].